The Inquirer tested unregulated, possibly dangerous “magic mushroom” based products sold at Philly smoke shops. Plus, how ...

When methylone was finally banned in 2011, unregulated chemists simply tweaked the molecule to evade the ban, creating new ...

Foxglove, a flowering plant long feared for its toxicity, became an unlikely source of a widely studied heart drug. Digoxin, ...

Coverage of a new PCSK9 trial makes bold claims about prevention and risk reduction. But how well do they hold up to scrutiny ...

Discusses Surprising Futility Results in Phase III Trial of Retogatein for Type 1 Diabetes March 30, 2026 9:00 ...

Sign up for the top news stories every day to keep you informed with what's going on in the West Midlands. Did you know with a Plus subscription to Express and Star ...

Corcept Therapeutics has secured US approval for its selective glucocorticoid receptor agonist, Lifyorli (relacorilant), in ovarian cancer more than three months before its Prescription Drug User Fee ...

This article is part of “Innovations In: Kidney Disease,” an editorially independent special report that was produced with financial support from Vertex. More than one in seven people in the U.S. have ...

A former drug addict said that ketamine should be a Class A drug as data revealed the number of people being treated in Suffolk for using it has risen by 251% since 2022. Drawing from the National ...

Alume Biosciences delivers positive topline results for three pivotal trials of Bevonescein, advancing toward NDA submission with US FDA in 2H 2026 Even with meticulous technique, surgeons are limited ...

Aziza Shuler is the Weekend Morning Anchor and Reporter at CBS News New York. Before arriving in New York, Aziza served as the weekend evening anchor and reporter at CBS News Philadelphia. New York ...

"By combining proteomics-driven experimental evidence with next-generation AI modeling, we are revealing opportunities that were previously invisible to classical drug discovery methods." Said Eran ...